Introduction
For the vast majority of people in the United States, the initiation of alcohol use begins during adolescence. A high percentage (12%) of adolescents begin using alcohol during middle school (8 th grade), and prior to high school graduation the vast majority of people in the United
States (80-90%) have consumed alcohol (Johnston et al., 2004) . In combination with moderate alcohol consumption, adolescents engage in binge drinking episodes. Self-reports have indicated that 22 and 28% of 10 th and 12 th grade students, respectively, reported an incident of binge drinking within the past two weeks (Johnston et al., 2004) . College students report a previous high level of binge drinking during high school (70%), frequent on-going episodes of binge drinking during college (44%), and a subset of college students are frequent binge drinkers (19-25% report more than 3 episodes of binge drinking per week; Wechsler et al., 1995 Wechsler et al., , 2000 SAMHSA, 2006) .
Alcohol consumption during adolescence is associated with a number of deleterious consequences. Age of first drink and the propensity to have binge EtOH drinking episodes during adolescence is associated with increased alcohol involvement, heavier drinking bouts, arrests for driving with ability impaired, and an increased rate of alcohol dependence during adulthood (Hingson et al., 2006 (Hingson et al., , 2008 Chou and Pickering, 1992) . Epidemiological studies have associated with maturation of reward and motor pathways (c.f., Crews et al., 2007) . The glutamatergic and serotonergic systems directly activate VTA DA neurons in adults. Alterations in these neurotransmitter systems within the VTA by adolescent EtOH consumption may alter the response of the VTA to EtOH during adulthood (c.f., McBride et al., 2005) .
Adolescent EtOH consumption can alter the mesolimbic dopamine system. Adolescent
EtOH consumption (Sahr et al., 2004) , as well as peripheral EtOH injections (Bandanich et al., 2007) can increase basal dopamine levels or dopamine reuptake in the AcbSh during adulthood.
Similar results are not produced in adult rats with comparable EtOH exposure paradigms (Pascual et al., 2009 ). The mesolimbic dopamine system is altered in response to non-EtOH stimuli during adulthood following adolescent EtOH consumption. Consumption of EtOH during adolescence in rats results in greater DA release in the AcbSh following 'risky' choice responding compared to adolescent naïve controls (Nasrallah et al., 2011) .
Peri-adolescent alcohol drinking by alcohol preferring (P) rats has been reported to produce long-lasting alterations in the reinforcing effects of EtOH, as indicated by P rats with access to EtOH, compared to the water control group, acquiring acquisition of EtOH operant responding sooner, showing a greater resistance to extinguish responding, and having a more prolonged elevated level of relapse responding for EtOH (Rodd-Henricks et al., 2002a) .
However, CNS mechanisms underlying these long-lasting alterations have not yet been explored.
In naïve rats, EtOH is directly self-administered into the posterior, but not anterior, VTA (Rodd-Henricks et al., 2000) . The reinforcing properties of EtOH within the pVTA are dependent upon activation of VTA DA neurons (Rodd et al., 2005a) . Selective breeding for high alcohol preference (P rats) is associated with an increase in the sensitivity of the pVTA to the reinforcing properties of EtOH compared to Wistar rats (lower concentrations required to support
self-administration; Rodd et al., 2004; 2005a) . Chronic EtOH consumption (>10 weeks 24-hour free choice access) can further reduce the concentration of EtOH required to support selfadministration directly into the pVTA (Rodd et al., 2005b) . Exposure to repeated periods of excessive EtOH consumption can enhance the magnitude of EtOH self-administration (higher rate of self-administration for equivalent concentration) in P rats (Rodd et al., 2005c) . The biological bases for these effects are unknown.
The current experiments were designed to determine the effects of adolescent EtOH consumption on the actions of EtOH within the mesolimbic DA system during adulthood. The first experiment determined if adolescent EtOH consumption would alter the self-infusion of EtOH directly into the pVTA. The second experiment determined if adolescent EtOH consumption would alter the effects of EtOH microinjected directly into the pVTA to stimulate DA release in the AcbSh. The overall hypothesis was that adolescent EtOH consumption should enhance the reinforcing properties of EtOH within the pVTA and promote EtOH's ability to stimulate the mesolimbic DA system.
Methods

Subjects
The adolescent EtOH access procedures used herein followed published procedures from our laboratory (Rodd-Henricks et al., 2002a , Bell et al., 2003 , 2006 , Sahr et al., 2004 .
Male P rats were chosen for use in the current study because their rapid growth post-adolescence increases skull strength for earlier cannula placement surgery. Previous work (McKinzie et al., 1998a , Bell et al., 2003 has described the differences between male and female P rats in EtOH drinking at these ages as minimal. The main benefit of using the P rats is that they voluntarily
consume pharmacologically relevant levels of EtOH during adolescence, thus avoid stress of other administration procedures (e.g., repeated injections).
Animals were maintained in facilities fully accredited by the Association for the Assessment and Accreditation of Laboratory Animal Care. All research protocols were approved by the Indiana University School of Medicine (Indianapolis, Indiana) Institutional Animal Care
and Use Committee and were in accordance with the guidelines of the Institutional Care and Use
Committee of the National Institute on Drug Abuse, the NIH, and the Guide for the Care and Use of Laboratory Animals (2011).
Peri-Adolescent EtOH Exposure Procedure
Pups were single-housed in hanging stainless steel cages (Allentown Caging Equipment
Co, Allentown, New Jersey) on PND 28. Subjects were initially maintained on a 12-hour light/dark cycle, lights on at 0900. On PND 30, subjects received either ad lib water or continuous access to 15% v/v EtOH and water, until PND 60 as previously described (RoddHenricks et al., 2002a) . Food was available ad lib. Bottle and body weights for all subjects were recorded every other day.
On PND 60, EtOH access ceased, and subjects were pair-housed in standard shoebox cages, within the same treatment condition. Subjects were also immediately transferred to a 12-hour reverse dark/light cycle, lights off at 1000, to optimize rats' nocturnal activity levels for later procedures. After PND 60, subjects received no further oral EtOH intake experience.
Intracranial self-administration (ICSA) procedure
Test chambers (Coulbourn Instruments, Allentown, Pennsylvania) were situated in sound-attenuating cubicles, as described previously (Rodd-Henricks et al., 2000, Rodd et al.,
2004b). ICSA was performed as previously described (Rodd-Henricks et al., 2000 , Rodd et al., 2004 . After postnatal day 75, the rats were implanted under isoflurane anesthesia with a guide cannula (22 gauge, Plastics One) stereotaxically aimed 1.0 mm above the pVTA. Coordinates were 5.8 to 6.1 mm posterior to bregma, 2.1 mm lateral, and 8.5 mm ventral from the surface of the skull at a 10 degree angle from the vertical (Paxinos and Watson, 1986) . A place-holding stylet (28 gauge, Plastics One) extending 0.5 mm beyond the tip of the guide cannula was inserted at all times, except during test sessions. Subjects were single-housed post surgery, and allowed to recover for 7 days. Starting three days prior to testing, subjects were handled 5 min per day.
All infusates were prepared freshly on the day of the experiment. Artificial cerebrospinal fluid (aCSF) was used as the vehicle for ICSA infusions. This injection vehicle consisted of (in mM) 120.0 NaCl, 4.8 KCl, 1.2 KH2PO4, 1.2 MgSO4, 25.0 NaHCO3, 2.5 CaCl2, and 10.0 Dglucose, all filtered through a sterile filter (pore size 0.2 µM) as previously described (RoddHenricks et al., 2000 , Rodd et al., 2004b . Ethyl EtOH (190 proof; McCormick Distilling Co., Weston, Missouri) was dissolved in the vehicle solution to the correct concentration. When necessary, 0.5 N HCl was added to adjust the pH to 7.4 (±0.1).
ICSA was conducted similar to procedures previously described (Rodd-Henricks et al., 2000 , Rodd et al., 2004 . Briefly, subjects were brought to the testing room, the stylet was removed, and an injection cannula/infusate cylinder was affixed in place. The injection cannula extended 1.0 mm beyond the tip of the guide, into the pVTA. A single, noncontingent administration of infusate was given at the beginning of the session during this insertion procedure in order to prime the system. Test sessions occurred every other day. No operant shaping techniques were used. Active lever and inactive lever sides were counterbalanced
between subjects, remaining the same for each individual rat. Within each 4 hr session, responses on the active lever resulted in 5 sec infusions on a fixed ratio 1 schedule of reinforcement.
During infusion and time-out (5 sec), responses on the active lever were recorded, but did not produce further infusions. Responses on the inactive lever were recorded but did not result in infusions at any time; these responses were used to index non-specific bar-pressing activity.
During ICSA sessions 1 through 4 (acquisition), subjects received their respective dose of either the aCSF vehicle or EtOH. During ICSA sessions 5 and 6 (extinction), all subjects received aCSF vehicle only, and in session 7 (reinstatement), the original concentration was made available.
A total of 82 P males were used in the experiment (n = 41/41 adolescent naïve/adolescent drinkers). Rats from the adolescent groups were randomly assigned to groups that selfadministered 0 (aCSF), 50, 75, 100, or 150 mg% EtOH directly into the pVTA (adolescent naïve -n = 6-10/group; adolescent drinkers -n = 7-10/group).
Microinjection-Microdialysis Procedure
Experimental housing was composed of Plexiglas chambers (40 x 28 x 40 cm).
Polyethylene tubing connected to a dedicated Harvard pump (Harvard Apparatus, Holliston, Massachusetts) was used to administer aCSF continuously throughout the experiment for microdialysis in the AcbSh. The connection to the EMIT unit for microinjection administration to the pVTA was identical to that used in the ICSA experiment, although automated control of jpet.aspetjournals.org Downloaded from
Microdialysis probes were prepared as approximately 2-mm loop style probes, as previously described (Perry and Fuller, 1992 , Engleman et al., 2000 , Melendez et al., 2002 .
Probes were manufactured in the laboratory with regenerated cellulose Spectra/Por ® hollow fiber microdialysis tubing, molecular weight cut off of 13,000. In our laboratory, these have been previously found to have approximately 15% DA recovery, which is an average recovery rate for this design and probe length (Justice, 1993) .
Adolescent EtOH treatment occurred as in the first experiment. Food and water were available ad lib at all times, except during Microinjection-Microdialysis testing. MicroinjectionMicrodialysis was performed as previously described (Ding et al., 2011) . After PND 75, and under isoflurane anesthesia, a microinjection guide cannula (22 gauge, Plastics One) was implanted in the right hemisphere of each subject, stereotaxically aimed 1.0 mm above the pVTA. Coordinates were 5.8 to 6.1 mm posterior to bregma, 2.1 mm lateral, and 8.5 mm ventral from the surface of the skull at a 10 degree angle from the vertical (Paxinos and Watson, 1986) .
A place-holding stylet (28-gauge, Plastics One) extending 0.5 mm beyond the tip of the guide cannula was inserted at all times, except during final experimentation. Also in the right hemisphere, a guide cannula (18 gauge, Plastics One) was implanted, aimed 3.0 mm above the AcbSh. Coordinates were 1.7 mm anterior to bregma, 2.3 mm lateral, and 5.4 mm ventral to the surface of the skull at a 10 degree angle from the vertical (Paxinos and Watson, 1986) . A placeholding stylet (Plastics One) extending 0.5 mm was inserted at all times, except during final experimentation.
Subjects were single-housed post surgery, and allowed to recover 6 days. Three days prior to testing, subjects were habituated to the testing chambers, 3 hours per day. One day before testing, microdialysis probes were inserted into the AcbSh under isoflurane anesthesia.
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When inserted, the dialyzing loop was oriented in an anterior-posterior direction to maximize exposure to the AcbSh. The probe extended 3 mm below the guide cannula, into the AcbSh.
The next day, the Microinjection-Microdialysis procedure was performed. Subjects were placed in the experimental chambers and the microdialysis probe tubing was connected to the pump for aCSF perfusion. The aCSF microdialysis perfusion medium was composed (in mM) as has been previously described (Melendez et al., 2002) of 145.0 NaCl, 2.7 KCl, 1.0 MgCl2, 2.5
CaCl2, and 2.0 Na2HPO4, filtered through a sterile filter (pore size 0.2 µM), always prepared fresh the day of the procedure. When necessary, pH was adjusted to 7.4 with 0.1 N acetic acid.
Flow speed of the perfusion medium was 1 µL/min. Microdialysis outflow was collected for 15 min per sample. After at least 90 min of washout flow, at least three baseline dialysate samples were collected. This was followed by one microinjection dialysate sample.
During the microinjection sample, the pVTA-cannula stylet was removed and the injection cannula/infusate cylinder affixed in place. The injection cannula extended 1.0 mm beyond the tip of the guide, into the pVTA. Administration of infusate occurred automatically, as programmed into the EMIT machine. Each subject received microinjections of one solution only, prepared identically to that in the ICSA experiment; either infusate vehicle aCSF, or 50, 75, 100, or 200 mg% EtOH. All subjects received the same volume of microinjections. Microinjections were composed of a series of 100 nL boluses, each delivered over an interval of 5 sec. This was repeated every 20 sec for a total of 30 microinjections over a 10 min period into the pVTA.
Following the microinjection sample, 120 min of post-injection dialysate samples were collected. All samples were collected into tubes containing 5 µL of 0.1 N perchloric acid. After collection, samples were immediately frozen on dry ice and stored at -70 degrees C until HPLC analysis for DA content.
This article has not been copyedited and formatted. The final version may differ from this version. A total of 74 P males were used in the microdialysis experiment (n = 37/37 adolescent naïve/adolescent drinkers). Rats from the adolescent groups were randomly assigned to groups that microinjected with 0 (aCSF), 50, 75, 100, or 150 mg% EtOH directly into the pVTA (adolescent naïve -n = 6-10/group; adolescent EtOH drinkers -n = 6-9/group).
All microdialysis samples were analyzed with microbore HPLC-EC to determine extracellular levels of DA. Samples were loaded into a 10 µL sample loop and injected onto an analytical column. Detector output ran to a computer program for analysis (ChromPerfect, Justice Innovations, Inc., Palo Alto, California). DA levels were then determined by comparison with a standard curve. The lower sensitivity limit for DA was estimated to be 0.1 nM. Complete details of HPLC procedure have been previously published (Sahr et al., 2004) .
Histologies
Upon termination of the experiments, a solution of 1% bromophenol blue dye was injected into the infusion site and the animals sacrificed. Brains were removed and immediately frozen at -70 °C, for slicing into 40-um sections with a cryostat microtome. Slides were stained with cresyl violet and examined for infusion site verification using the atlas of Paxinos and Watson (1986) .
Statistical Analysis
EtOH consumption was analyzed as pure EtOH intake (grams of EtOH per kilogram of body weight, g/kg). Change in preference ratio for EtOH intake vs. water was calculated by 
Preference data were averaged in six blocks of 5 days, analyzed with a repeated measures ANOVA and linear regression between blocks.
ICSA data were analyzed with a Dose x Session mixed ANOVA, with repeated measures on Session performed on the number of active lever responses and the number of infusions separately. For each individual group, lever discrimination was determined by "lever (active vs.
inactive) x session" mixed ANOVA with repeated measures on session. Post hoc Tukey's b tests were employed when a significant main effect was found, p < 0.05. Extinction was determined by comparing the responses on the active lever during sessions 4, 5, and 6, while reinstatement was determined by comparing the responses on the active lever during sessions 5, 6, and 7.
Microdialysis data were expressed as a percentage of basal DA values, to correct for betweensubject baseline variability, as previously described (Engleman et al., 2006) . Basal dialysate values for each subject were calculated as the mean of three baseline samples prior to the injection sample. Also, absolute levels of baseline DA were calculated, and compared as group means between the two peri-adolescent Exposure Groups. The effects of peri-adolescent EtOH administration on basal extracellular DA levels and maximal drug effect with each Dose was calculated using Student's t-test. The effects of EtOH microinjection administration on extracellular DA levels as a function of time and adolescent treatment condition were analyzed using a two-way Adolescent Group x Time analysis of variance (ANOVA), with repeated measures on Time (15-min samples), followed by the Tukey's post hoc test. Alpha was set at a P < 0.05 significance level.
Results
Adolescent EtOH Consumption
This article has not been copyedited and formatted. The final version may differ from this version. Initial consumption for all peri-adolescent EtOH-exposed subjects was 5.17 ±0.36 g/kg/day (data not shown). At the end of the access period, consumption was 7.80 ±0.31 g/kg/day. A repeated measures within subjects ANOVA performed on the average intake in 5 day blocks revealed there was a significant main effect of Day (F 5,51 = 5.627, p < 0.001),
indicating that EtOH consumption changed over time. There was no significant effect of Study Group (ICSA and Microinjection-Microdialysis groups consumed equivalent amounts of EtOH;
F 1, 55 = 1.948, p = 0.168). The amount of EtOH consumed would be predicted to produce significant, pharmacologically relevant (> 50 mg%) blood alcohol concentrations (Bell et al., 2003 (Bell et al., , 2004 (Bell et al., , 2006 .
ICSA EtOH Dose Response
A multifactorial ANOVA was performed on the average number of infusions selfadministered from sessions 1-4 (Fig. 1) . The analysis indicated a significant Adolescent Group x EtOH concentration interaction (F 4,72 = 2.85; p = 0.031). Reducing the interaction term was performed by examining the average number of infusions for each EtOH concentration. In rats self-administering aCSF, 50 mg%, or 150 mg%, there was no effect of Adolescent Group on infusions self-administered (F values < 2.4; p values > 0.14). In contrast, there was a significant difference between Adolescent Group (EtOH > Naïve) in P rats self-infusing 75 or 100 mg% Fig, 3 ; bottom left panel). In the 7 th session, there was also a significant effect of EtOH concentration on active lever responding (F 4,36 = 3.52; p = 0.017) with post-hoc comparisons indicating that the 100 and 150 mg% groups were significantly different than all other groups (Fig, 3 ; left panels). Analysis for lever discrimination indicated that the adolescent naïve P rats self-infusing 150 mg% EtOH discriminated between responding on the active and inactive lever during sessions 2, 3, 4, and 7 (p values < 0.004). Adolescent naïve P rats given 100 mg% EtOH only expressed lever discrimination during the 7 th session (p < 0.001). The 150 mg% EtOH group displayed extinction when aCSF was substituted (sessions 5 and 6), with a significant reduction from session 4 to sessions 5 (p = 0.003) and 6 (p = 0.02). The 100 and 150 mg% EtOH groups displayed reinstatement of EtOH self-infusions (significantly higher level of active lever responding during session 7 compared to session 6; p values < 0.001).
In adolescent EtOH drinkers, EtOH self-infusions occurred at lower concentrations and at a higher levels (Figs. 2 and 3) . In adolescent EtOH drinkers, there was a significant EtOH This article has not been copyedited and formatted. The final version may differ from this version. Contrasting the adolescent naïve and EtOH drinkers at each individual EtOH concentration for active lever responding during each session provide evidence for enhanced responding by the adolescent EtOH drinkers. For rats self-infusing 75, 100 and 150 mg% EtOH directly into the pVTA, adolescent EtOH drinkers responded more on the active lever during sessions 2, 3, 4, and 7 than did adolescent naïve rats (all p values < 0.013).
Microinjection-Microdialysis EtOH Dose Response
Similar to the ICSA data, the microdialysis experiment indicated that the pVTA of adolescent EtOH drinkers was more responsive than adolescent naïve rats to EtOH (Fig. 4) In adolescent naïve rats ( Fig. 4 ; top panel), there was a significant EtOH concentration x Time interaction term (F 24,192 = 3.16; p < 0.001). Performing individual ANOVAs for each sample period revealed significant EtOH concentration differences in the AcbSh during sample periods 1,2, 3, 5, and 6 following microinjection (F 4,32 values > 3.8; p values < 0.013). Post-hoc comparisons indicated that for all these times points, adolescent naïve rats administered 150 mg% EtOH directly into the pVTA had significantly higher DA levels in the AcbSh than all other groups.
In adolescent EtOH drinkers ( Fig. 4 ; bottom panel), there was also a significant EtOH EtOH microinjection into the pVTA, the DA levels in the AcbSh of adolescent drinkers receiving 75, 100, and 150 mg% EtOH were higher than rats receiving microinjections of aCSF or 50 mg% EtOH. During the 3 rd -7 th sample period following EtOH microinjection into the pVTA, the DA levels in the AcbSh of adolescent EtOH drinkers receiving 100, and 150 mg% EtOH were higher than in subjects receiving microinjections of aCSF, or 50 or 75 mg% EtOH.
Body Weights
Adolescent EtOH consumption in P rats did not alter body weight growth (data not shown). Statistical analysis revealed a significant main effect of day (F 7,96 = 1370.7, p < 0.001), but no significant main effect of exposure group (F 1,102 = 0.257, p=0.613) or Day x Exposure Group interaction (F 7,96 = 1.53, p=0.167).
Discussion
The findings of the current experiments indicate that peri-adolescent EtOH consumption by male P rat pups produces neuroadaptations that results in individuals being more susceptible to the reinforcing and stimulatory actions of EtOH within the pVTA during adulthood.
Specifically, adolescent EtOH consumption results in a greater sensitivity to EtOH (lower concentrations required to establish intracranial self-administration), and a propensity to receive more self-infusions of EtOH at a given concentration within the pVTA (Figs. 1-3 pVTA to increase DA release in the AcbSh (Fig. 4) . In addition, in adolescent EtOH drinkers and naïve subjects given the same concentration of EtOH microinjected into the pVTA, the amount of DA released and the duration of the increase in DA release in the AcbSh was increased by adolescent EtOH consumption (Fig. 4) .
The effects of EtOH consumption during adolescence on adult EtOH consumption is inconsistently reported in the literature. However, like every aspect of alcohol studies, the manner, amount, and duration of EtOH exposure is likely to affect the observed consequences of EtOH consumption. Non-physiologically relevant levels of alcohol consumption (EtOH intake levels that would produce no significant blood EtOH concentration) during adolescence have been shown to have no effect on adult EtOH consumption (Slawecki and Betancourt, 2002; Slawecki, 2004; Slawecki et al., 2004; Siegmund et al., 2005) . Significant consumption of sweetened EtOH in Sprague-Dawley adolescent rats increases adult consumption of sweetened EtOH but not unadulterated high EtOH concentration solutions (20%; Broadwater et al., 2013) .
Injections of EtOH during adolescence can result in a conditioned taste aversion to sweetened solutions and indeterminate effects on adult EtOH consumption (Gilpin et al., 2012) . In contrast, adolescents injected with EtOH in a manner that does not produce taste aversion can enhance adult EtOH consumption (Pascual et al., 2007 (Pascual et al., , 2009 Maladonado-Devincci et al., 2010) .
Voluntary EtOH drinking during adolescence at a level that produces pharmacologically relevant levels of EtOH has been shown to enhance adult EtOH consumption (Walker and Ehlers, 2009; Strong et al., 2010; O'Tousa et al., 2013) . In P rats, adolescent EtOH consumption (oral freechoice) increases the acquisition of EtOH self-administration (operant), decreases the rate of extinction of EtOH self-administration, enhances relapse drinking, and enhances the ability of a priming dose of EtOH to increase EtOH-seeking (Rodd-Henricks et al., 2002a) . These effects of This article has not been copyedited and formatted. The final version may differ from this version.
adolescent EtOH consumption in P rats were not observed in adult P rats given similar drinking exposure (Rodd-Henricks et al., 2002b) . The current data is the first reported evidence that periadolescent EtOH consumption can increase adult EtOH self-infusions directly into a brain region that is a critical component of the neurocircuitry regulating drug reward.
In adults, chronic EtOH consumption (> 8 weeks) enhances the reinforcing properties of EtOH within the pVTA (Rodd et al., 2005b) . Exposure to repeated cycles of EtOH access and deprivation (> 16 weeks of EtOH) further enhanced the alteration in the reinforcing properties of EtOH within the pVTA (Rodd et al., 2005c) . The effects of adult EtOH consumption on the ability of EtOH microinjected into the pVTA to stimulate DA release in the AcbSh have not been examined. However, neuroadaptations produced by peri-adolescent EtOH consumption may not be identical to that observed following chronic adult EtOH consumption, but the overall impact is similar. Future studies need to determine if these neuroadaptations are consistent or unique between peri-adolescent and adult EtOH consumption.
Adolescent exposure to EtOH has been shown to alter DA within the mesolimbic DA system. Multiple studies have indicated that systemic administration of EtOH during adolescence results in higher basal DA levels in the Acb (Badanich et al., 2007; Pascual et al., 2009 ).
Comparable EtOH injections in adolescent and adult rats result in higher basal level of DA in the Acb in adolescent rats (Pascual et al., 2009) . Adolescent EtOH consumption in P rats increases DA clearance without a change in the extracellular concentration of DA within the Acb, suggesting increased DA neurotransmission (Sahr et al., 2004) . In addition, adolescent EtOH consumption in P rats enhances and prolongs DA release in the Acb (both shell and core were assessed) following systemic administration of EtOH during adulthood (Sahr et al., 2004 protocol), but an estimate of basal DA levels indicate that adolescent drinkers had higher basal DA levels in the AcbSh (approximately 22%). Therefore, the significant percent of baseline enhancement of DA levels in the AcbSh following EtOH microinjection into the pVTA in adolescent EtOH drinkers was observed despite possible higher basal DA levels (Fig. 4) . Similar to the findings of Sahr et al. (2004) with i.p.EtOH injections, the ability of pVTA EtOH to stimulate DA release in the Acb was prolonged following adolescent EtOH consumption.
Therefore, adolescent EtOH consumption in P rats results in a prolonged DA response in the Acb following both systemic and pVTA exposure to EtOH during adulthood.
The majority of research examining the effects of adolescent EtOH exposure has centered on the amygdala and hippocampus (learning associated effects; c.f. Spear and Varlinskaya 2005; Gulley and Juraska, 2013) . The biological basis of the neuroadaptations in the pVTA produced by EtOH consumption during adolescence in the P rat was not directly examined in the current experiments. The data indicate 3 possibly distinct neuroadaptations (increased sensitivity to EtOH reinforcement in pVTA, increased pVTA DA neuronal response to EtOH, and a prolonged effect of EtOH on pVTA DA neurons) produced by adolescent EtOH consumption in the pVTA, which may involve unique, non-overlapping neuronal systems. EtOH self-infusion directly into the pVTA requires DA neuronal activity (Rodd et al., 2004) and can be reduced by coadministration of 5HT 3 receptor antagonists . It is possible that these systems may be altered by adolescent EtOH consumption, or exposure to other drugs of abuse during adolescence. Adolescent exposure to amphetamine (PND 30 to PND 50) results in an increase in basal firing rates of VTA DA neurons and 5HT neurons in the dorsal raphe (Labonte et al., 2012 Overall, the data indicate that adolescent EtOH consumption in the P rat, a rodent model of alcoholism, produced persistent alterations in the drug reward pathway that is indicative of increased sensitivity to EtOH and a potentiated/prolonged response to EtOH. The increase in reward sensitivity during adulthood following adolescent EtOH consumption maybe the biological basis for the deleterious effects that adolescent alcohol consumption has on adult alcoholism. Elucidating specific neuroadaptations within the mesolimbic DA system produced by adolescent EtOH consumption could lead to interventions/treatments to counter the consequences of this common human behavior. indicates significantly more infusions than aCSF controls and 50 mg% group (adolescent naïve -n = 6-10/group; adolescent drinkers -n = 7-10/group). (left panels) and adolescent drinkers (right panels) given 100 mg% (top panels) or 150 mg% EtOH (bottom panels) to self-administer directly into the posterior VTA. * indicates significantly more responding on the active lever than that observed in aCSF controls and discrimination between levers. + indicates significantly more responding on the active lever than that observed in aCSF controls, discrimination between levers, and significantly more responding in the adolescent drinkers than adolescent naïve rats. 
